Delivery Order SPE2DB22D1106-SPE2DB24FEYC6

Award Date 6/20/24
Potential Completion Date 7/12/24
Potential Value $1.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for $1,615.33 to supply ENVARSUS XR 4 MG TABLET 100S. This order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and Amerisourcebergen, valued up to $999,999,999.00 through December 31, 2025. Under this IDC, Amerisourcebergen provides a comprehensive range of pharmaceutical products and...
The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, a firm fixed price delivery order contract valued at $1,615.33 to provide ENVARSUS XR 4 MG TABLET 100S. This award is under Amerisourcebergen's existing indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary vehicle for Amerisourcebergen to deliver pharmaceuticals and medical supplies to DLA Troop...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of ENVARSUS XR 0.75 MG TABLET 30S, a pharmaceutical product. The contract has a ceiling value of $5,518.20 and an ultimate completion date of August 2, 2024. This award is under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31,...
The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract worth $3,648.33 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply ENVARSUS XR 1 MG TABLET 100S. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded by DLA to Amerisourcebergen Drug Corp, which serves as the primary vehicle for the company to provide pharmaceutical products and medical supplies...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $1,216.11 contract is for the provision of ENVARSUS XR 1 MG TABLET 100S, a pharmaceutical product, with a period of performance through April 22, 2024. This delivery order is a task order under an indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential value of up to...
The Defense Logistics Agency (DLA) awarded a $1,621.48 firm-fixed-price delivery order to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of ENVARSUS XR 1 MG TABLET 100S. This order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a wide range of pharmaceutical products and medical supplies to the Department of Defense globally. The...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract, contract number SPE2DX15D3201|SPE2DX24F2V9R, to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide ENVARSUS XR 1 MG TABLET 100S, a pharmaceutical product, with a ceiling value of $1,216.11 and a period of performance through April 29, 2024. This delivery order contract is part of a larger indefinite delivery contract (IDC) valued up to...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract, valued at $11,313.46, is for the delivery of ENVARSUS XR 4 MG TABLET 100S to support military treatment programs and facilities. Amerisourcebergen Drug Corp, the prime contractor, serves as the primary supplier of pharmaceutical products...
The Defense Logistics Agency Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of ENVARSUS XR 1 MG TABLET 100S. The contract has a completion date of March 8, 2024 and a potential value of $1,216.11. This delivery order contract is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and...
The U.S. government agency, the Defense Logistics Agency (DLA) Troop Support Medical, has awarded a delivery order contract to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $1,621.48 firm fixed price contract is for the delivery of Envarsus XR 1 mg tablets to support military treatment programs and facilities. This order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB24FEYC6
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division, valued at $1,465.68, for the supply of the pharmaceutical product ENVARSUS XR 1 MG TABLET 30S. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. Under this IDC, Amerisourcebergen provides a comprehensive range of pharmaceutical products and medical supplies to support the DLA's mission of delivering logistics, acquisition, and technical services to the U.S. Armed Forces and other government agencies. The contract does not have a set-aside designation, indicating it was awarded on a full and open competition basis.

Generated 9/19/24, 9:55 AM